TargEDys develops new microbiome-based solutions for appetite regulation and announces a €5.8M international round of financing to demonstrate product clinical efficacy.
14 April 2016

TargEDys develops new microbiome-based solutions for appetite regulation and announces a €5.8M international round of financing to demonstrate product clinical efficacy.

TargEDys, an innovator in appetite regulation, announces a €5.8M “Series A” fundraising round based on world-leading research from company founders Serguei Fetissov and...

Read the press release

By continuing your browsing on this site, you accept the use of cookies to carry out statistics of anonymous visits. Read more

Authorize Refuse